CVI Investments, Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-22 09:59 am Purchase | 2025-07-15 | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments, Inc. | 100,000 5.700% | 64,411 (+180.99%) | Filing |
| 2025-07-21 11:16 am Sale | 2025-06-30 | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments, Inc. | 35,589 4.900% | -13,331 (-27.25%) | Filing |
| 2025-05-01 10:01 am Purchase | 2025-04-24 | 13G | BRIACELL THERAPEUTICS CORP BCTX | CVI Investments, Inc. | 48,920 8.600% | 44,920 (+1123.00%) | Filing |